Add like
Add dislike
Add to saved papers

Effects of Blue Light on Puberty and Ovary in Female Rats.

PURPOSE: This study was planned to examine the effect of blue light exposure and exposure time on puberty.

METHODS: Eighteen 21-day-old female Sprague Dawley rats were divided into three groups consisting of six rats in each group: Control Group (CG), Blue Light-6 hours (BL-6), and Blue Light-12 hours (BL-12). CG rats were maintained with 12/12-hour light-dark cycles. The rats of BL-6 and BL-12 were exposed to blue light(450-470nm/irradiance level 0.03uW/cm2) for 6 hours and 12 hours, respectively. Rats were exposed to blue light until the first signs of puberty. Serum FSH, LH, Estradiol, testosterone, DHEA-S, leptin, and melatonin were studied by the ELISA method. Ovaries and uterus were dissected for histomorphological examination.

RESULTS: The medians of the pubertal entry days of the CG, BL-6, and BL-12 were 38th ,32th , and 30th days, respectively (p:0.001). The FSH, testosterone, DHEA-S, and leptin concentrations of all groups were similar. However, LH and estradiol concentrations of BL-6 were higher compared to CG. There was a negative correlation between blue light exposure, exposure time, and melatonin concentrations (r=-0.537, p=0.048). Ovarian tissue was compatible with the pubertal period in all groups. As the blue light exposure time increased, capillary dilatation and edema in the ovarian tissue increased. Prolonged exposure caused polycystic ovary-like (PCO) morphological changes and apoptosis in granulosa cells. Our study is the first to show the effects of blue light exposure on puberty.

CONCLUSION: Our study showed that exposure to blue light and the duration of exposure lead to early puberty in female rats. As the duration of blue light exposure increased, PCO-like, inflammation, and apoptosis were detected in the ovaries.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app